KALY - Kali-Extracts Releases 2019 $20 Million Revenue Partnership Update
January 04 2019 - 1:26PM
InvestorsHub NewsWire
KALY - Kali-Extracts Releases 2019
$20 Million Revenue Partnership Update
Dallas, TX -- January 4, 2019
-- InvestorsHub NewsWire -- Kali, Inc. (dba/Kali-Extracts)
(USOTC:
KALY) (“KALY”) today released a 2019 New Year message published
by North American Cannabis Holdings, Inc. (USOTC:
USMJ) (“USMJ”) that includes an outline of KALY’s role in the
partnership with the USMJ family of companies. In addition to
discussing the overall objectives of the USMJ family of companies
with an initial revenue goal totaling $20 million, the New Year
message emphasizes that KALY has recently updated all its financial
reports required by OTCMarkets to satisfy the OTCMarkets “current”
filing standards and anticipates the OTCMarkets site to soon
reflect KALY’s “current” filing status. KALY also has a
coming analyst research report scheduled for publication on
Tuesday, January 8th, 2019 to provide shareholders with
an extensive market analysis of the company’s business plan and
progress toward its business plan objects. The analyst report
is expected to include detail on KALY’s recent $400,000 in new
contracts and the $5 million in revenue expected from KALY’s hemp
farming initiative with Nouveau (USOTC:
NOUV). The release from USMJ today is included in its entirety
below:
USMJ CEO 2019 New Year Msg
Outlining $20 M Revenue Goal for USMJ Family of
Companies
North American Cannabis Holdings,
Inc. (USOTC:
USMJ) (“USMJ”) today released a 2019 New Year message from the
CEO and Chairman Steven Rash. Mr. Rash is also the President
and Chairman of ACI Conglomerated, the majority shareholder of
USMJ. His letter, included below in its entirety, provides an
update on pending key events for USMJ and the USMJ family of
companies to include, Puration, Inc. (USOTC:
PURA) (“PURA”), Kali, Inc. (dba/Kali-Extracts) (USOTC:
KALY), Nouveau Life Pharmaceuticals, Inc. (dba/Nouveau)
(USOTC:
NOUV) and Priority One Aviation (Pending Name Change)(USOTC:
PJET)(“PJET”). ACI Conglomerated is the majority
shareholder of all of the USMJ family of companies except for
KALY. KALY is part of the family through contract. PURA
has licensed KALY’s patented cannabis extraction process for the
production of cannabis infused beverages and PURA and KALY are
partners in a joint venture with NOUV called US Cannabis
Health. Combined, with a specific by company breakout
included in the letter below, the USMJ family of companies have an
initial revenue goal totaling $20 million. As some of the
companies in the family of companies have not yet set revenue
goals, the total goal is expected to increase by the end of the
first quarter. Read more below:
Dear Shareholders
–
Let me start by wishing all a
Happy New Year. I consider 2018 to have been a great year for
the USMJ family of companies and I anticipate 2019 to be a pivotal
year for the US cannabis industry at large and in turn, a
tremendous year for USMJ, PURA, KALY, NOUV and
PJET.
As I have noted in a previous
communication, the legalization of hemp farming in the United
States under the 2018 Farm Act is the biggest thing yet to happen
to the cannabis sector world-wide and potentially the biggest event
that will ever happen in the cannabis sector. On behalf of
all our companies, I’m excited about the prospects of having US
domestic hemp for the production of CBD. This will be a
watershed event for KALY and PURA.
Even knowing the CBD aspect of
legal hemp farming is a watershed event for KALY and PURA, I also
know that legal hemp farming is much, much bigger than just CBD
production. I am not understating anything when I tell you
that hemp farming will have a massive economic impact worldwide,
not just in the agriculture sector, but across the entire global
economy. Legal hemp farming in the US will permeate through
the pharmaceutical sector, the construction sector, the fashion
sector and the energy sector to name just a few. Hemp farming
is anticipated to generate $50,000 per acre and with NOUV launching
its first 100 acres of hemp this year, you could see NOUV ringing
$5 million in revenue in 2019.
While legal hemp farming, in my
opinion, is the biggest event that will ever happen to the cannabis
sector, I anticipate another cannabis sector event will get rolling
this year that garners even more media attention than hemp
farming. As 2019 winds down toward the 2020 Presidential
Election, I anticipate we will see President Trump push for the
legalization of recreational marijuana as part of his
campaign. Between hemp farming and the likely advance toward
the legalization of recreational marijuana, I expect 2019 to be a
huge year for established entrepreneurial cannabis sector
companies. I believe “USMJ” will become one of the most
notable brand names in the cannabis sector.
So, with all the enthusiasm I can
muster, Happy New Year to all. USMJ’s revenue goal for its
soon to be launched ecommerce site is $10 million. PURA’s
cannabis beverage sales goal is $5 million. KALY and NOUV
anticipate $5 million in sales form their combined efforts with the
100-acre hemp farm. PJET has not yet set a revenue goal for
its new AmeriCanna Cafe business and KALY and NOUV have not set
individual revenue goals separate from their combined hemp farming
initiative. In addition to the $20 million in combined sales
goals for the USMJ family of companies, USMJ shareholders will soon
be receiving a dividend of PJET stock, and PURA shareholders will
soon be receiving a dividend of NOUV stock. The dividend
issuance is taking a little longer than anticipated but is still on
track. KALY has recently updated all its financial reports
required by OTCMarkets and anticipates the OTCMarkets site to soon
reflect KALY’s current filing status. KALY also anticipates
publishing an analyst research report on Tuesday, January
8th, 2019 to provide shareholders with an extensive
market analysis of the company’s business plan and progress toward
its business plan objects.
Please keep a lookout on
OTCMarkets and each of the companies’ websites for the latest
updates in what we expect to be a very exciting
2019.
Sincerely,
Steven Rash
CEO and Chairman
USMJ and ACI
Conglomerated
www.growusmj.com
www.purationinc.com
www.kali-extracts.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Steven
Rash
CEO
North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350
Kali, Inc.
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Oct 2023 to Oct 2024